7Baggers
Quarterly
Annual
    Unit: USD2025-07-04 2025-04-04 2025-01-03 2024-09-27 2024-06-28 2024-03-29 2023-12-29 2023-09-29 2023-06-30 2023-03-31 2022-12-30 2022-09-30 2022-07-01 2022-04-01 2021-12-31 2021-10-01 2021-07-02 2021-04-02 2021-01-01 2020-10-02 2020-07-03 2020-04-03 2020-01-03 2019-09-27 2019-06-28 2019-03-29 2018-12-28 2018-09-28 2018-06-29 2018-03-30 2017-12-29 2017-09-29 2017-06-30 2017-03-31 2016-12-30 
      
    		                                   
      cash flows from operating activities:
    		                                   
      net income
    		-89,100,000 7,100,000 -100,000 -49,900,000 1,500,000 1,600,000 -400,000 32,000,000 9,200,000 4,300,000 3,200,000 13,200,000 8,400,000 7,600,000 1,600,000 8,800,000 12,200,000 3,200,000 -6,300,000                 
      adjustments to reconcile net income to net cash from operating activities:
    		                                   
      share-based compensation expense
    		3,700,000 3,800,000 4,100,000 3,500,000 3,900,000 4,200,000 3,700,000 3,400,000 3,600,000 3,200,000 3,300,000 3,300,000 3,400,000 3,900,000 3,400,000 3,300,000 3,400,000 3,600,000 3,600,000 3,200,000 3,700,000 3,300,000 3,200,000 3,000,000 3,100,000 3,000,000 2,600,000 2,500,000 2,800,000 2,600,000 2,100,000 2,300,000 2,500,000 1,300,000 2,300,000 
      depreciation
    		5,800,000 5,600,000 6,200,000 5,600,000 5,300,000 5,200,000 5,100,000 5,300,000 4,900,000 4,700,000 4,600,000 4,700,000 4,700,000 4,800,000 4,800,000 5,000,000 5,000,000 5,300,000 5,200,000 5,000,000 5,900,000 6,200,000 5,200,000 4,800,000 4,600,000 4,300,000 9,800,000 10,000,000 5,500,000 5,600,000 4,900,000 6,300,000 2,100,000 5,400,000 3,100,000 
      amortization of intangible assets
    		1,000,000 1,000,000 900,000 1,000,000 1,700,000 3,600,000 3,600,000 3,500,000 3,400,000 3,400,000 3,400,000 3,400,000 3,700,000 3,700,000 3,800,000 4,100,000 4,200,000 4,300,000 4,200,000 4,100,000 4,200,000 4,400,000 4,500,000 4,300,000 4,100,000 3,600,000 3,700,000 3,700,000 4,100,000 4,200,000 4,200,000 4,300,000 3,600,000 1,300,000 1,300,000 
      deferred taxes
    		-3,400,000 100,000 100,000 51,300,000 -7,700,000 -5,800,000 -800,000 -38,400,000 -700,000 -200,000 -200,000 -900,000 1,000,000 300,000 200,000 -3,500,000 400,000 0 100,000 12,500,000 -15,900,000 -200,000 500,000 -7,200,000 -3,100,000 -100,000 -2,500,000 6,300,000 -2,900,000 -1,200,000 -9,900,000 -16,700,000 900,000 1,700,000 5,200,000 
      income from equity method investments
    		   1,200,000 1,400,000 -200,000 -400,000 1,500,000    1,100,000 -100,000    -300,000    900,000 1,400,000 -700,000  1,000,000 500,000 -800,000  0       
      amortization of deferred loan costs, net of premium
    		700,000 800,000 800,000                                 
      gain on purchase of business
    		   0 0 0 -2,100,000                             
      impairment of goodwill
    		                                   
      inventory write-down
    		1,400,000 1,100,000 500,000 1,500,000 800,000 1,700,000 900,000 1,800,000 1,200,000 600,000 2,000,000 1,100,000 3,700,000 1,200,000 400,000 0 0   2,300,000    0            
      other
    		-2,200,000 500,000 1,900,000 -500,000 700,000 1,800,000 -500,000 800,000 -300,000   2,400,000 300,000 300,000 1,100,000 600,000 -300,000 300,000 700,000 4,000,000 500,000   -200,000 -400,000 1,300,000 100,000 1,300,000    1,200,000 0 400,000 200,000 
      changes in assets and liabilities:
    		                                   
      accounts receivable
    		8,600,000 -7,900,000 19,500,000 -5,700,000 -600,000 -12,300,000 25,300,000 -400,000 -3,800,000 -1,600,000 15,600,000 -16,200,000 -3,200,000 -27,100,000 28,400,000 -7,400,000 -19,300,000 -8,400,000 2,200,000 -13,900,000 16,900,000 -3,800,000 18,500,000 -10,300,000 -4,300,000 8,800,000 20,600,000 -23,500,000 -1,900,000 800,000 33,600,000 -30,300,000 6,900,000 -9,600,000 9,900,000 
      inventories
    		-16,500,000 -5,500,000 -15,600,000 14,600,000 3,800,000 1,400,000 -13,200,000 18,500,000 11,600,000 8,900,000 -18,800,000 -3,900,000 -34,600,000 -22,700,000 -23,800,000 18,200,000 4,200,000 17,900,000 2,500,000 7,400,000 -15,900,000 -13,100,000 -21,100,000 15,100,000 200,000 -4,400,000 -22,000,000 7,300,000 1,300,000 -1,400,000 -9,600,000 19,900,000 -8,900,000 -8,500,000 -6,700,000 
      prepaid expenses and other assets
    		-700,000 -2,200,000 -2,400,000 2,800,000   2,200,000 3,000,000 5,900,000 -1,500,000 -400,000 5,700,000 3,500,000 -2,300,000 3,400,000 13,700,000 500,000 -13,100,000 -2,000,000 -1,600,000 -1,800,000 -9,600,000 3,700,000 -400,000 2,200,000 -1,200,000 3,700,000 -800,000 1,500,000   -3,300,000 400,000 -5,400,000 -2,400,000 
      accounts payable
    		0 4,800,000 6,800,000 -10,100,000 -200,000 -1,900,000 9,000,000 -11,300,000 -100,000 -11,600,000 8,000,000 -5,100,000 4,400,000 6,900,000 13,500,000 -7,600,000 13,800,000 -15,600,000 -4,200,000 -7,400,000 700,000 5,600,000 15,400,000 -4,700,000 -1,600,000 -2,200,000 -500,000 7,900,000 4,500,000 -8,700,000 1,500,000 -5,800,000 3,400,000 9,200,000 -1,900,000 
      accrued liabilities and other current and long-term liabilities
    		300,000 4,700,000 -16,400,000 10,100,000 -2,000,000 4,800,000 -22,000,000 11,500,000 700,000 12,200,000 -25,400,000 7,900,000 -4,600,000 12,300,000 -30,500,000                     
      deferred revenues
    		4,800,000 1,300,000 1,500,000 -200,000 -1,900,000 600,000 -800,000 -1,200,000 700,000 1,100,000 1,700,000  3,900,000 -1,000,000 -500,000 500,000 -200,000 600,000 -300,000 -900,000 -2,300,000 2,000,000 -800,000 -3,300,000 0 -500,000 -1,400,000 2,300,000 500,000 100,000 -500,000 400,000 0 -1,500,000 -500,000 
      net cash from operating activities
    		7,700,000 16,600,000 9,500,000 25,900,000 8,000,000 3,100,000 10,300,000 47,100,000 37,700,000 27,300,000 -3,700,000 17,100,000 -2,700,000 -8,300,000 10,800,000 50,600,000 22,100,000 12,800,000 7,100,000 -11,800,000 1,100,000 900,000 23,000,000 22,900,000 16,100,000 12,900,000 20,000,000 18,500,000 21,300,000 5,400,000 40,100,000 14,800,000 26,800,000 13,800,000 19,200,000 
      capex
    		-6,500,000 -6,600,000 -3,500,000 0 -4,200,000 -7,400,000 -7,900,000 1,400,000 400,000 -6,700,000 -3,500,000 -9,500,000 -3,900,000 -3,100,000 -3,300,000 -2,000,000 -4,200,000 -4,000,000 -3,400,000 -3,500,000 -5,100,000 -6,000,000 -7,300,000 -4,900,000 -6,100,000 -5,400,000 -1,600,000 -5,600,000 -11,400,000 -800,000 -600,000 -10,000,000 -2,100,000 -1,700,000 -2,400,000 
      free cash flows
    		1,200,000 10,000,000 6,000,000 25,900,000 3,800,000 -4,300,000 2,400,000 48,500,000 38,100,000 20,600,000 -7,200,000 7,600,000 -6,600,000 -11,400,000 7,500,000 48,600,000 17,900,000 8,800,000 3,700,000 -15,300,000 -4,000,000 -5,100,000 15,700,000 18,000,000 10,000,000 7,500,000 18,400,000 12,900,000 9,900,000 4,600,000 39,500,000 4,800,000 24,700,000 12,100,000 16,800,000 
      cash flows from investing activities:
    		                                   
      purchases of property, plant, and equipment
    		-6,300,000 -6,800,000 -4,200,000  -4,700,000 -5,800,000 -10,400,000                             
      proceeds from sales of marketable debt securities
    		0 1,000,000 9,500,000                                 
      proceeds from maturities of marketable debt securities
    		4,800,000 29,900,000 10,600,000 13,600,000 15,000,000 16,000,000 14,200,000 11,600,000 5,200,000 7,500,000 4,000,000                         
      purchase of marketable debt securities
    		0 -9,200,000 -21,400,000 -19,500,000 -2,000,000 -10,600,000 -24,500,000 -18,600,000 -23,700,000 -3,600,000 -6,300,000                         
      purchase of marketable equity securities
    		   0    0 0 0 -2,700,000                         
      proceeds from maturities of certificates of deposit
    		0 0 3,400,000                                 
      settlement of net investment hedge
    		       0 0 0 7,000,000                         
      acquisitions of businesses, net of cash acquired
    		   0 0 0 900,000             -400,000 0 0 -1,200,000 0        4,200,000    
      net cash from investing activities
    		-700,000 14,700,000 -3,000,000 -14,000,000 7,700,000 -1,300,000 -19,900,000 -14,600,000 -22,800,000 -3,800,000 -3,700,000 -27,500,000 -14,300,000 -4,000,000 -2,600,000 -3,300,000 -4,500,000 -4,000,000 -4,400,000 -3,700,000 -5,900,000 -6,700,000 -10,600,000 -6,800,000 -78,800,000 -4,200,000 -3,400,000 -10,500,000 -8,400,000 -4,300,000 -2,600,000 -8,400,000 -276,900,000 -2,400,000 -4,300,000 
      cash flows from financing activities:
    		                                   
      taxes related to net share settlement of equity awards
    		0 -700,000 -1,200,000 -300,000 -100,000 -800,000 -1,000,000 0 0   -700,000 0   0 0   0 0   0 0   0 0   0 0   
      proceeds from issuance of senior secured notes
    		0 0 126,900,000                                 
      repayments of borrowing under credit agreements
    		-200,400,000 -400,000 -700,000  -400,000 -400,000 -400,000  -500,000 -700,000 -500,000  -600,000 -28,100,000 -300,000  -700,000 -1,300,000 -200,000  -181,500,000 -18,700,000 -17,800,000 -21,300,000 -13,700,000 -33,000,000 -19,000,000 -10,000,000 -18,000,000 -46,000,000 -32,000,000 -21,000,000 -230,200,000   
      payment of debt issuance costs
    		-700,000   -100,000 -600,000               -8,200,000 -8,000,000   0 0       0    
      proceeds from shares issued under employee stock purchase plan
    		0   1,800,000 0   1,900,000 0   1,300,000 1,900,000 0 1,700,000 0 1,600,000 0 1,200,000 0 1,800,000 0 1,800,000 0 1,900,000 0 1,900,000 0 1,900,000 0 1,400,000     
      net cash from financing activities
    		-201,200,000 -700,000 124,900,000 800,000 -1,100,000 -1,300,000 -1,700,000 1,400,000 -700,000 -500,000 -400,000 200,000 1,400,000 -30,400,000 5,000,000 -31,000,000 -300,000 -3,200,000 2,200,000 26,900,000 68,800,000 -100,000 -12,000,000 -14,800,000 60,300,000 -32,500,000 -13,100,000 -8,900,000 -14,800,000 -39,900,000 -26,800,000 -12,600,000 259,800,000 14,300,000 1,800,000 
      effects of exchange rate changes on cash and cash equivalents and restricted cash
    		500,000       200,000    -100,000 0 0 -100,000 0    1,900,000 -800,000 100,000 -300,000 0 -100,000 -200,000 -400,000         
      net increase in cash and cash equivalents and restricted cash
    		-193,700,000 30,400,000 131,400,000 12,600,000 14,600,000   34,100,000 14,100,000 23,000,000 -7,800,000 -10,300,000 -15,600,000 -42,700,000 13,100,000 16,300,000 17,200,000 5,600,000 4,900,000 13,300,000 63,200,000 -5,800,000 100,000    3,100,000         
      cash and cash equivalents and restricted cash at beginning of period
    		0 0 170,400,000 0 0 0 154,000,000 0 0 0 90,600,000 0 0 0 146,100,000 0 0 0 102,100,000 0 0 0 31,300,000 0 0 0 53,400,000         
      cash and cash equivalents and restricted cash at end of period
    		-193,700,000 30,400,000 301,800,000 12,600,000 14,600,000 500,000 142,700,000 34,100,000 14,100,000 23,000,000 82,800,000 -10,300,000 -15,600,000 -42,700,000 159,200,000 16,300,000 17,200,000 5,600,000 107,000,000 13,300,000 63,200,000 -5,800,000 31,400,000 1,300,000 -2,500,000 -24,000,000 56,500,000         
      supplemental cash flow information:
    		                                   
      cash paid for interest
    		16,700,000 200,000 13,700,000 0 13,800,000 100,000 13,700,000 0 13,600,000 100,000 13,700,000 0 13,700,000 1,000,000 14,800,000 600,000 17,000,000 200,000 3,800,000 5,100,000 2,400,000 4,200,000 5,000,000 6,200,000 4,600,000 6,100,000 3,000,000 4,700,000 4,700,000 4,900,000 5,000,000 5,400,000 3,500,000   
      income taxes paid, net of refunds
    		3,100,000 7,800,000 6,200,000        4,500,000                         
      supplemental non-cash activities:
    		                                   
      purchases of property, plant, and equipment financed through accounts payable
    		-200,000 200,000 700,000  500,000 -1,600,000 2,500,000                             
      loss (income) from equity method investments
    		 1,400,000 1,700,000                            700,000     
      impairment of equity method investment
    		                                   
      amortization of deferred loan costs
    		   700,000 800,000 600,000 700,000 700,000 600,000 700,000 600,000 2,800,000 2,800,000 2,700,000 2,600,000     2,800,000 1,100,000 600,000 600,000 600,000 600,000 600,000 600,000 600,000 500,000 600,000 600,000 1,200,000    
      loss on operating lease abandonment
    		           0 0 0 1,900,000                     
      purchases of property, plant and equipment
    		         -5,600,000 -5,500,000 -9,800,000 -4,000,000 -3,400,000 -4,100,000 -2,600,000 -4,700,000 -3,400,000 -4,400,000 -4,000,000 -5,300,000 -6,100,000 -8,100,000 -6,500,000 -5,700,000 -4,200,000 -3,400,000 -5,100,000 -8,400,000 -4,300,000 -2,600,000 -12,600,000 -900,000 -1,700,000 -5,000,000 
      loss on settlement of cash flow hedge
    		       0 0 100,000 -300,000                         
      purchase of certificates of deposit
    		                                   
      proceeds from sales of business and assets
    		           0 0 0 1,700,000                     
      investments in and loans to privately-held companies
    		           -300,000 0                       
      repayments of borrowings
    		                                   
      proceeds from exercise of stock options
    		           0 0 300,000 3,500,000     0 0 400,000 1,100,000 600,000 100,000   300,000 1,300,000 400,000 1,800,000 0 2,200,000   
      other financing activities
    		           0 100,000 -500,000 100,000 -100,000 -1,200,000 -600,000 -100,000 -1,100,000 -500,000 0 -100,000          0   
      cash paid for income tax, net of refunds
    		                                   
      purchases of property, plant and equipment financed through accounts payable
    		       1,400,000 400,000 -1,100,000 2,000,000 300,000 100,000 300,000 800,000 600,000 500,000 -600,000 1,000,000 500,000 200,000 100,000 800,000 1,600,000 -400,000 -1,200,000 1,800,000 -500,000 -3,000,000 3,500,000 2,000,000 2,600,000 -1,200,000 0 2,600,000 
      income taxes paid, net of
    		     10,100,000 2,700,000  3,000,000    2,800,000                       
      net decrease in cash and cash equivalents and restricted cash
    		      -11,300,000                  -2,500,000           
      other assets impairment charges
    		                                   
      acquisitions of businesses and assets
    		                                   
      proceeds from issuance of debt
    		                                   
      (income) income from equity method investments
    		         600,000 -1,300,000                     1,700,000 -2,600,000 -300,000 -100,000 
      impairment of intangible assets
    		                       0 4,000,000   0        
      proceeds from issuance of warrant
    		                                   
      purchases of hedges
    		                   0                
      purchases of marketable securities
    		                                   
      borrowings under credit agreements
    		                0 200,000 1,300,000  68,200,000 20,500,000 3,000,000 6,400,000 72,000,000 3,000,000 4,000,000 0 0 8,000,000 2,000,000 5,000,000 538,000,000   
      income from equity method investments, net of dividends received
    		              500,000                     
      cash paid for income tax
    		              400,000  1,100,000 8,500,000 4,400,000  400,000 5,900,000 500,000 4,400,000 3,500,000 -300,000 600,000 1,200,000 700,000 11,700,000 200,000 3,400,000    
      changes in assets and liabilities, net of effects of acquisitions:
    		                                   
      accrued operating liabilities and other long-term operating liabilities
    		                       11,400,000 3,900,000 -7,500,000 3,100,000 -3,200,000 -1,000,000 -7,100,000 1,100,000 18,600,000 7,100,000   
      investments in privately-held companies
    		                   700,000 -600,000               
      amortization of debt issuance costs and discounts
    		                2,500,000 2,500,000 2,400,000                 
      impairment of assets
    		                                   
      changes in assets and liabilities, net of effects of acquisition:
    		                                   
      accrued liabilities and other current and long-term operating liabilities
    		                -4,000,000 7,900,000 -2,700,000  10,100,000 5,700,000 -4,800,000             
      investments and loans to privately-held companies
    		                -200,000                   
      proceeds from issuance of convertible debt
    		                                   
      proceeds from issuance of warrants
    		                                   
      gain from equity method investments
    		                  1,700,000                 
      net earnings
    		                   -26,200,000 -28,200,000 -1,800,000 -1,200,000 8,200,000 -1,300,000 5,900,000 3,000,000 400,000 4,000,000 12,500,000 11,400,000 15,000,000 10,800,000 15,000,000 11,200,000 
      adjustments to reconcile net earnings to net cash from operating activities:
    		                                   
      gain from equity method investments, net of dividends received
    		                                   
      contributions from noncontrolling partner
    		                                   
      contributions and advances to joint ventures
    		                      -1,300,000             
      net transfers from parent
    		                                   
      distributions to varian medical systems, inc.
    		                                   
      excess tax benefits from share-based compensation
    		                                   
      dividends paid to redeemable noncontrolling interest
    		                                   
      transfers of property, plant and equipment from varian medical systems, inc.
    		                               1,200,000 -900,000   
      other non-cash transfers to varian medical systems, inc.
    		                                   
      (gain) income from equity method investments
    		                                   
      sale of available-for-sale securities
    		                                   
      increase in restricted cash
    		                                   
      net transfers from (to) parent
    		                               1,700,000   1,800,000 
      effects of exchange rate changes on cash and cash equivalents
    		                           0 -700,000 100,000 100,000 200,000 0 0 700,000 
      net increase in cash and cash equivalents
    		                           -900,000 -2,600,000 -38,700,000 10,800,000 -6,000,000 9,700,000 25,700,000 17,400,000 
      cash and cash equivalents at beginning of period
    		                           0 0 0 83,300,000 0 0 0 36,500,000 
      cash and cash equivalents at end of period
    		                           -900,000 -2,600,000 -38,700,000 94,100,000 -6,000,000 9,700,000 25,700,000 53,900,000 
      distribution to varian medical systems, inc.
    		                                -27,100,000   
      distribution payable to varian medical systems, inc.
    		                                   
      other non-cash transfers from parent
    		                                   
      tax effect of (windfalls) shortfalls from share-based compensation
    		                                   
      accrued liabilities and other long-term liabilities
    		                                  -2,400,000 
      transfers of property, plant and equipment from varian
    		                                  12,300,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.